STATKING Clinical Services (SCS), a Genesis Drug Discovery and Development (GD3) Company, is proud of its 30 year history of service to emerging pharmaceutical and medical device clients. Since the company's founding in 1989, the company has evolved from providing statistical consulting and data analysis services on a variety of household products to a full service Contract Research Organization (CRO) serving the pharmaceutical and medical device industries. Today, the company employs a staff of product development specialists that are heavily involved in all phases of the Client's development program including protocol development, medical monitoring and clinical trial management. STATKING's highly experienced team of professionals has been instrumental in achieving regulatory approval for a number of new medical devices, drugs and biologics. At STATKING, our team is committed to providing services that meet or exceed all Federal Guidelines and Regulations for Good Clinical Practice. Service Areas: Protocol Development, Clinical Trial Management, Medical Monitoring, Clinical Study Monitoring, Medical Writing, Regulatory Submissions, Biostatistics, SAS Programming, Clinical Data Management and Safety Monitoring. Therapeutic Areas: Radiopharmaceuticals, Diagnostics, Oncology, CNS, Women's Health, GI, Orthopedic and Bone, Cardiac, Pain Management, Autism Spectrum Disorder, Fragile-X Syndrome, Rare and Orphan Diseases